What's happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled

The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here's the latest. DNA-testing company 23andMe (Nasdaq: ... Lees verder

Bron:

Fast Company